Dr. Martens (DOCS.L) Stock Analysis & Winston Score
Dr. Martens is a British footwear company best known for its iconic lace-up boots with thick, air-cushioned soles. The brand has been around since 1960 and sells shoes, boots, and sandals to consumers around the world, particularly younger adults who are drawn to its distinctive style. It is one of the most recognizable boot brands globally, with the classic 1460 boot being its signature product. The company makes money by selling footwear through its own retail stores, its website, and third-party retailers like department stores and independent shoe shops. Dr. Martens operates across the Americas, Europe, and Asia-Pacific, with the UK and US being its largest markets. The brand's strong cultural identity and loyal customer base give it some pricing power, but the company has faced falling sales and profitability pressure in recent years as consumer spending on discretionary items has weakened, making a recovery in demand its key near-term challenge.
Winston Score: 58/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (19/30)
- Growth: Mixed (7/20)
- Cash Flow: Exceptional (9/10)
- Stability: Good (5/10)
- Valuation: Good (6/10)
- Ownership: Good (10/15)
Key Facts
Price: 81.80 GBp
Market Cap: £783M
Sector: Consumer Cyclical
Industry: Apparel - Footwear & Accessories
Exchange: London Stock Exchange


